BlackRock’s Takeda Pharmaceutical TAK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$54.9M Buy
3,550,877
+920,044
+35% +$14.2M ﹤0.01% 2366
2025
Q1
$39.1M Buy
2,630,833
+426,982
+19% +$6.35M ﹤0.01% 2482
2024
Q4
$29.2M Buy
2,203,851
+313,174
+17% +$4.15M ﹤0.01% 2768
2024
Q3
$26.9M Buy
1,890,677
+454,325
+32% +$6.46M ﹤0.01% 2806
2024
Q2
$18.6M Sell
1,436,352
-558,236
-28% -$7.22M ﹤0.01% 2985
2024
Q1
$27.7M Buy
1,994,588
+222,646
+13% +$3.09M ﹤0.01% 2751
2023
Q4
$25.3M Sell
1,771,942
-522,527
-23% -$7.46M ﹤0.01% 2823
2023
Q3
$35.5M Sell
2,294,469
-112,430
-5% -$1.74M ﹤0.01% 2574
2023
Q2
$37.8M Sell
2,406,899
-139,117
-5% -$2.19M ﹤0.01% 2610
2023
Q1
$42M Buy
2,546,016
+460,180
+22% +$7.58M ﹤0.01% 2530
2022
Q4
$32.5M Sell
2,085,836
-145,161
-7% -$2.26M ﹤0.01% 2716
2022
Q3
$28.9M Buy
2,230,997
+53,234
+2% +$690K ﹤0.01% 2794
2022
Q2
$30.6M Sell
2,177,763
-843,511
-28% -$11.8M ﹤0.01% 2785
2022
Q1
$43.3M Buy
3,021,274
+842,139
+39% +$12.1M ﹤0.01% 2627
2021
Q4
$29.7M Buy
2,179,135
+365,186
+20% +$4.98M ﹤0.01% 2970
2021
Q3
$29.7M Buy
1,813,949
+138,422
+8% +$2.27M ﹤0.01% 2976
2021
Q2
$28.2M Buy
1,675,527
+307,522
+22% +$5.18M ﹤0.01% 3037
2021
Q1
$25M Buy
1,368,005
+1,367,308
+196,170% +$25M ﹤0.01% 3010
2020
Q4
$13K Buy
697
+39
+6% +$727 ﹤0.01% 4749
2020
Q3
$12K Buy
+658
New +$12K ﹤0.01% 4681
2020
Q1
Sell
-66
Closed -$1K 4979
2019
Q4
$1K Sell
66
-237
-78% -$3.59K ﹤0.01% 4890
2019
Q3
$5K Sell
303
-2,158
-88% -$35.6K ﹤0.01% 4732
2019
Q2
$43K Buy
2,461
+1,563
+174% +$27.3K ﹤0.01% 4542
2019
Q1
$18K Buy
898
+718
+399% +$14.4K ﹤0.01% 4565
2018
Q4
$3K Buy
+180
New +$3K ﹤0.01% 4756